Cerebral Sinus Hemodynamics in Adults Revealed by 4D Flow MRI

Abstract

BackgroundThe hemodynamics of the cerebral sinuses play a vital role in understanding blood flow‐related diseases, yet the hemodynamics of the cerebral sinuses in normal adults remains an unresolved issue.PurposeTo evaluate hemodynamics in the cerebral sinus of adults using 4‐dimensional flow MRI (4D Flow MRI).Study TypeCross‐sectional.PopulationNinety‐nine healthy volunteers (mean age, 42.88 ± 13.16 years old; females/males, 55/44).Field Strength/Sequence3 T/4D Flow MRI.AssessmentThe blood flow velocity, average blood flow rate (Q), and vortexes at the superior sagittal sinus (SSS), straight sinus (STS), transverse sinus, sigmoid sinus, and jugular bulb of each volunteer were evaluated by two independent neuroradiologists. The relationship between the total cerebral Q and sex and age was also assessed. Twelve volunteers underwent two scans within a month.Statistical TestsThe intraclass correlation coefficient (ICC) evaluated the inter‐observer agreement. Blood flow parameters among volunteers were compared by the independent‐sample t‐test or Mann–Whitney U test. The multiple linear regression equation was used to evaluate the relationship between total cerebral Q and age and sex. P < 0.05 indicated statistical significance.ResultsThe test–retest and interobserver reliability of average velocity and Q were moderate to high (ICC: 0.54–0.99). Cerebral sinus velocity varied by segment and cardiac cycle. The SSS's velocity and Q increased downstream and Q near torcular herophili was 3.5 times that through the STS. The total cerebral Q decreased by 0.06 mL/s per year (β = −0.06 ± 0.013) and was sex‐independent within the group. Vortexes were found in 12.12%, 8.9%, and 59.8% of torcular herophili, transverse‐sigmoid junction, and jugular bulb, respectively, and were related to higher upstream flow.Data ConclusionCerebral sinuses could be measured visually and quantitatively in vivo by 4D Flow MRI, providing a basis for future research on pulsating tinnitus, multiple sclerosis, and other related diseases.Evidence Level2Technical EfficacyStage 1